Last reviewed · How we verify

NCT06213272

Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits

Recruiting now NA Last updated 21 May 2025
What this trial tests

NA trial testing Phono-Motor Therapy in Stroke in 70 participants. Currently enrolling.

Timeline
18 April 2024
Primary endpoint
1 March 2029
1 March 2029

Quick facts

Lead sponsorKessler Foundation
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment70
Start date18 April 2024
Primary completion1 March 2029
Estimated completion1 March 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kessler Foundation

Who can join

Adults 18 to 85, any sex, with Stroke or Aphasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the proposed project is to test the effectiveness of a novel hybrid approach to treatment of reading disorders after stroke, in which exercise training will be used in combination with a targeted reading treatment. This approach is expected to increase cerebral circulation and help to rebuild and strengthen the damaged phonological neural networks. Through this combinatory approach, the study aims to enhance the reading and language improvements seen with existing treatments.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Improving reading competence in aphasia with combined aerobic exercise and phono-motor treatment: Protocol for a randomized controlled trial.
    Boukrina O, Madden EB, Sandroff BM, Cui X, et al · · 2025 · PMID 39820216 · DOI 10.1371/journal.pone.0317210

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Kessler Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06213272.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing